Drugs / Iron dextrose
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03286205 Comparator | Apr 2015 → Aug 2018 | iron deficiency anemia | Sutter Gould Medical Foundation | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron dextrose | “The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.” NCT03286205 ↗ |
| Route | Intravenous | “IV iron infusion based on weekly or every 3 week dosage.” NCT03286205 ↗ |